DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Methoxyamine is an investigational drug.
There have been 6 clinical trials for Methoxyamine. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lymphoma, and Lung Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Case Comprehensive Cancer Center, and [disabled in preview].
There are three US patents protecting this investigational drug and thirty-five international patents.
Recent Clinical Trials for Methoxyamine
|Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma||National Cancer Institute (NCI)||Phase 2|
|Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer||National Cancer Institute (NCI)||Phase 1|
|Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Cisplatin and Pemetrexed||National Cancer Institute (NCI)||Phase 1/Phase 2|
Top disease conditions for Methoxyamine
Top clinical trial sponsors for Methoxyamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Methoxyamine||See Pricing||4-substituted pyrazolo[3,4-d]pyrimidine derivatives||Ortho Pharmaceutical Corporation (Raritan, NJ)||See Pricing|
|Methoxyamine||See Pricing||Macrolide compounds||American Cyanamid Company (Stamford, CT)||See Pricing|
|Methoxyamine||See Pricing||Benzo[1,8]naphthyridine derivatives, their preparation and the compositions which contain them||Laboratoire Roger Bellon (Seine, FR)||See Pricing|
|Methoxyamine||See Pricing||Inosose derivatives, production and use thereof||Takeda Chemical Industries, Ltd. (Osaka, JP)||See Pricing|
|Methoxyamine||See Pricing||7-substituted bicyclic pyrazolidinones||Eli Lilly and Company (Indianapolis, IN)||See Pricing|
|Methoxyamine||See Pricing||Process for the preparation of substituted 3-amino-2 (benzoyl)-acrylic acid esters, and a process for the preparation of intermediates for antibacterial active compounds from these compounds||Chemie Linz Gesellschaft m.b.H. (Linz, AT)||See Pricing|
|Methoxyamine||See Pricing||Optically active hydroxybenzylamine||Sumitomo Chemical Company, Limited (Osaka, JP)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Methoxyamine||European Patent Office||0331510||2008-03-03||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|